BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezhilarasan D. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021;458:152840. [PMID: 34175381 DOI: 10.1016/j.tox.2021.152840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Malik R, Joshi N, Tomer VK. Functional graphitic carbon (IV) nitride: A versatile sensing material. Coordination Chemistry Reviews 2022;466:214611. [DOI: 10.1016/j.ccr.2022.214611] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Liao C, Zhang L, Jiang R, Xu J, Tang J, Hu K, Jiang S, Li L, Yang Y, Huang J, Tang L, Li L. Inhibition of NAD kinase elevates the hepatic NAD+ pool and alleviates acetaminophen-induced acute liver injury in mice. Biochemical and Biophysical Research Communications 2022;612:70-6. [DOI: 10.1016/j.bbrc.2022.04.079] [Reference Citation Analysis]
3 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
4 Gürler M, Selçuk EB, Özerol BG, Tanbek K, Taşlıdere E, Yıldız A, Yağın FH, Gürel E. Protective effect of dexpanthenol against methotrexate-induced liver oxidative toxicity in rats. Drug Chem Toxicol 2022;:1-9. [PMID: 35655424 DOI: 10.1080/01480545.2022.2084103] [Reference Citation Analysis]
5 Zekić T, Benić MS, Radić M. Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatol Int 2022. [PMID: 35604436 DOI: 10.1007/s00296-022-05143-y] [Reference Citation Analysis]
6 Gheena S, Ezhilarasan D, Shree Harini K, Rajeshkumar S. Syringic acid and silymarin concurrent administration inhibits sodium valproate-induced liver injury in rats. Environ Toxicol 2022. [PMID: 35543257 DOI: 10.1002/tox.23557] [Reference Citation Analysis]
7 Han J, Liu L, Meng L, Guo H, Zhang J, Han ZQ, Hong ZY. Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies. Front Oncol 2021;11:759805. [PMID: 35004279 DOI: 10.3389/fonc.2021.759805] [Reference Citation Analysis]
8 Balak DMW, Piaserico S, Kasujee I. Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies. Psoriasis (Auckl) 2021;11:151-68. [PMID: 34909410 DOI: 10.2147/PTT.S342911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Latif MS, Azad AK, Nawaz A, Rashid SA, Rahman MH, Al Omar SY, Bungau SG, Aleya L, Abdel-Daim MM. Ethyl Cellulose and Hydroxypropyl Methyl Cellulose Blended Methotrexate-Loaded Transdermal Patches: In Vitro and Ex Vivo. Polymers (Basel) 2021;13:3455. [PMID: 34685214 DOI: 10.3390/polym13203455] [Reference Citation Analysis]
10 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]